Either active immunization with trehalose-6, 6'-dimycolate (cord factor)-methylated bovine serum albumin complex or passive transfer of rabbit anticord factor serum induced in mice an enhanced resistance against infection with virulent human Mycobacterium tuberculosis. This suggests that the anticord factor antibody exerts an infection-protecting effect by neutralizing the toxic action of cord factor during the course of living virulent infection with tubercle bacilli. The protective effect of active immunization with cord factormethylated bovine serum albumin complex and of anti-cord factor serum was found to be specific for the tuberculous infection among a number of experimental infections in mice with a variety of cytopathogenic microorganisms tested.
A previous paper from this laboratory (12) has described a method for producing a precipitating and neutralizing antibody to trehalose-6, 6'-dimycolate (cord factor) of Mycobacterium tuberculosis in mice and rabbits by the vaccination with cord factor-methylated bovine serum albumin (MBSA) complex. The accompanying communication (13) gives evidence that this antibody to cord factor resides predominantly in 19S immunoglobulin M fraction of serum of rabbits vaccinated with cord factor-MBSA complex, and that no antibody response to cord factor was elicited in man and laboratory animals by the infection with virulent M. tuberculosis.
Another series of studies on the biochemical basis of the toxicity of cord factor demonstrated that this toxic glycolipid of M. tuberculosis induced either in vivo (8, 15) or in vitro (10, 11) a structural damage of the mitochondrial membrane system and a functional defect in the respiration and accompanying phosphorylation in mouse liver mitochondria. From these observations, it was assumed that cord factor plays a certain role in the virulence of tubercle bacilli by interfering with the basic metabolic activity in host cells.
Since the anti-cord factor antibody neutralizes the toxic action of cord factor both in vivo and in vitro (12) , the above hypothetical role of cord factor in the virulence of tubercle bacilli was studied by testing the effect of either active immunization with cord factor-MBSA com-14 plex or passive transfer of rabbit anti-cord factor serum on the experimental tuberculosis in mice. The results demonstrated that anticord factor antibody protects mice against the infection with virulent tubercle bacilli, which suggests that cord factor plays an important role in the pathogenesis of tuberculosis.
MATERIALS AND METHODS Animals. Male albino mice of random-bred ddO stock (8) 4 to 8 weeks of age and rabbits of both sexes weighing 3 kg were maintained as previously described (12) .
Cord factor and related compounds. Cord factor, mycolic acid, and acetylated cord factor were prepared from human tubercle bacilli, strain H37Rv, as previously reported (11) . Methyl 6-mycoloyl-a-Dglucopyranoside and 6, 6'-dimycoloyl sucrose (14) were supplied by J. Asselineau, Laboratoire de Biochimie Structurale et Metabolique, Universite Paul Sabatier, Toulouse, France. An aqueous emulsion of these natural and semisynthetic lipids was prepared by the previously reported method (11) .
Vaccination. Cord factor-MBSA complex was prepared as reported in a previous paper (12 Serum of rabbits was prepared 10 to 14 days after the last injection of cord factor-MBSA complex and 6 weeks after the BCG vaccination as previously described (12) .
Infection. Mice were infected by the intravenous inoculation with virulent human M. tuberculosis H37Rv grown for 7 days in Tween-albumin liquid medium (Difco Laboratories, Detroit, Mich.). For the inoculation into mice vaccinated with a mixture of cord factor and BSA, bacilli were collected by centrifugation, washed twice with 0.85% saline, and suspended in the initial culture volume of saline containing 0.02% Tween 80. Viable units in the inoculum were determined by plating serial dilutions of the culture with 0.1% BSA on oleic acid-albumin agar (Difco).
Listeria monocytogenes (NCTC 7973) of serotype I was obtained from G. B. Mackaness, Trudeau Institute, Saranac Lake, N.Y. The bacteria were cultered on brain heart infusion agar (Difco) for 17 hr at 37 C. Bacteria were harvested by washing the plate with Hanks balanced salt solution and injected intravenously into mice after appropriately diluting with the same medium. The bacteria contained in the inoculum were counted in a Petroff-Hauser chamber.
Brucella abortus A62 was supplied by K. Kanai, Department of Tuberculosis, National Institute of Health, Tokyo, Japan. The bacteria were cultured on Tryptose agar (Difco) for 48 hr at 37 C. Bacteria were collected by washing the plate with saline, and were appropriately diluted and injected intravenously into mice. Viable units in the inoculum were determined by plating serial dilutions of the bacterial suspension on Tryptose agar. Salmonella enteritidis no. 11 and S. typhimurium LT2 were obtained from K. Saito, Department of Microbiology, Keio University School of Medicine, Tokyo, Japan. The bacteria were grown on nutrient agar (Difco) for 18 hr at 37 C. Bacteria were collected by washing the plates with saline and were brought to an appropriate concentration and injected intraperitoneally into mice. The number of bacteria in the inoculum was determined by plating the increasing dilutions of the bacterial suspension on nutrient agar.
Enumeration of viable units of tubercle bacilli in the infected tissue. Lungs and spleen of mice infected with M. tuberculosis H37Rv were aseptically removed and ground with nine volumes (v/w) of sterile 2% BSA in a glass homogenizer of Potter-Elvehjem type. The tissue suspensions were diluted with sterile 0.1% BSA and 25 uliters of appropriate dilutions were plated on oleic acid-albumin agar (Difco). The plates were incubated for 2 and 3 weeks at 37 C, the colonies were counted, and the number of viable units in total organ was calculated from the dilution factor.
Histological procedures. Formalin-fixed mouse lungs were processed by conventional histological techniques and stained with hematoxylin and eosin.
RESULTS
Protective effect of cord factor-MBSA complex on experimental tuberculosis in mice. Figure 1 compares the survival curves of mice vaccinated with either cord factor-MBSA complex or live BCG vaccine with that of nonvaccinated control mice after a massive intravenous challenge with M. tuberculosis H37Rv. Mice vaccinated with cord tactor-MBSA complex showed an enhanced resistance to infection which was comparable to that observed in BCG-vaccinated animals. The weight of, and the number of viable units in, the lungs of mice at 30 days after challenge are shown in Table 1 . The lungs of nonvaccinated control mice were markedly enlarged and covered with numerous tubercles, whereas the macroscopic lesion in those of cord factor-MBSA-and BCG-vaccinated mice was minimal. Histologically, extensive exudative lesions were observed in the lungs of nonvaccinated control mice, whereas such lesions were hardly visible in the lungs of cord factor-MBSA-vaccinated mice (Fig. 2) . In close accord with these findings, the number of viable units in the cord factor-MBSA-vaccinated mouse lungs was 102 to 103 less than that recovered from the control mouse lungs. An almost identical level of bacterial counts was observed in the lungs of cord factor-MBSAand BCG-vaccinated mice (Table 1) . These results indicate that the protective effect of cord factor-MBSA complex against tuberculous infection is as potent as that of live BCG vaccine. Figure 3 demonstrates the bacterial counts in lungs and spleen recovered at weekly intervals after the infection of mice with M. tuberculosis H37Rv. An apparent prevention of the bacterial multiplication was observed in both lungs and spleen of the cord factor-MBSA-vaccinated mice. In lungs, the bacterial growth was supressed during the first 3 weeks after challenge, and a constant low level of viable in vivo population of tubercle bacilli was observed until week 8 in the vaccinated group. In spleen of the vaccinated mice, the increase in the number of viable tubercle bacilli during the first 3 weeks after challenge was not seen. Table 2 indicates that the protective potency of cord factor-MBSA complex against both the toxic action of cord factor and the infection with tubercle bacilli becomes appar-,15 VOL 7, 1973 on November against the toxicity of cord factor described in a previous paper (12) .
In an attempt to test the specificity of the infection-protecting effect of cord factor-MBSA complex, mice vaccinated with the complex were challenged with a number of cytopathogenic bacteria: listeria, brucellae, and salmonellae. The challenge doses of these organisms were adjusted to cause the deaths of control mice within 3 to 5 days after challenge. Table 4 shows that the infection-protecting effect of cord factor-MBSA complex is highly specific for the infection with M. tuberculosis. The vaccination with cord factor-MBSA complex protected mice against the infection with neither listeria, brucellae, nor salmonellae.
Effect of anti-cord factor serum on experimental tuberculosis in mice. The above results demonstrate that the active immunization with cord factor-MBSA complex protected mice against the infection with virulent M. tuberculosis. Since it has been shown in a previous paper (12) that the vaccination with cord factor-MBSA complex induced in mice and rabbits an antibody to cord factor which demonstrated a precipitin reaction with cord factor and neutralized its toxicity both in vivo and in vitro, it seems most likely that the anti-cord factor antibody displays the protection of infection by neutralizing the toxic action of cord factor in mice infected with virulent tubercle bacilli. To test this possibility, the pooled sera of cord factor-MBSAvaccinated rabbits (x 160 to x 320 antibody titer by precipitation) were subcutaneously injected into mice everyday starting 1 week before intravenous challenge with M. tuberculosis H37Rv. After challenge, the serum was injected every other day for 30 days. Control mice received no serum, nonvaccinated rabbit serum, or BCG-vaccinated rabbit serum. Figure 4 shows that injection of the serum of rabbits vaccinated with cord factor-MBSA complex produced in mice an enhanced resistance against infection with M. tuberculosis. During 30 days after a massive intravenous challenge with H37Rv, no death was observed in the group of mice injected with the serum of rabbits vaccinated with cord factor-MBSA complex, whereas all mice were dead by infection during this period in the groups of animals injected with no sera, control sera, and BCG-vaccinated rabbit sera. After the discontinuation of serum injection at 30 days, 60% of the mice that received the serum of cord factor-MBSA-vaccinated rabbits were dead in 2 Cord factor-MBSA.. 1, 1, 1, 1, 1, 1, 2, 2, 2, 2 1, 1, 1, 2,2, 2, 2, 3, 3, 3 Brucella abortus .. 4.0 x 106 3, 3, 3, 3, 3, 3, 3, 3, 4, 4  2, 3, 3, 3, 3, 3, 3 approaches by several investigators (5) (6) (7) 16) . Our previous study (16) of the effect of the direct addition of cord factor-in-oil on the tuberculous infection in mice failed to confirm the claim of Bloch and Noll (6) that cord factor enhances the multiplication of virulent tubercle bacilli in vivo. Recent development of a method of producing a neutralizing antibody against cord factor by the vaccination of animals with cord factor-MBSA complex (12) enabled us to reexamine this subject by using an immunological technique.
The facts that either the active immunization with cord factor-MBSA complex or the passive transfer of anti-cord factor serum protected mice against both the toxic action of cord factor (12) and the infection with virulent M. tuberculosis, that the bacterial multiplication in the organs of mice infected with tubercle bacilli was prevented by the vaccination with cord factor-MBSA complex or by the injection with anti-cord factor serum, and that the infection-protecting effect of cord factor-MBSA complex and of anti-cord factor serum was specific for the tuberculous infection indicate that cord factor plays an important role in the pathogenesis of tuberculosis. An earlier paper from this laboratory (7) presented indirect evidence that tubercle bacilli produce toxic substance(s) identical to cord factor during their multiplication in vivo. The present results that both the vaccination with cord factor-MBSA complex and the injection with anti-cord factor serum induced in mice an enhanced resistance against tuberculous infection add further and more substantial support to this view. It appears from the present study that cord factor enhances the multiplication of tubercle bacilli in vivo by affecting the basic metabolic activity of host-cell mitochondria (8, 10, 11, 15) . Anti-cord factor antibody seems to compete with this toxic action of cord factor and interfere with the in vivo proliferation of tubercle bacilli, resulting in a supression of the overall infectious processes in host tissues. Relevant to this assumption is the fact that vaccines, except live BCG, which were found to be ineffective for inducing antitoxic immunity to cord factor in vivo (12) showed no effective protection against the infection with virulent tubercle bacilli.
Although cord factor-MBSA complex proves to be an artificial immunogen as potent as live BCG vaccine against the experimental tuberculosis in mice, the mechanisms of the immunity induced by these agents are essentially different (12) . As reported in previous papers (9, 12) and confirmed in this study, BCG can neither protect mice against the toxic action of cord factor nor induce the production of anti-cord factor antibody in rabbit serum, despite its potent immunogenic activity against the tuberculous infection. It is also shown in the accompanying paper (13) that the infection with, or sensitization to, virulent M. tuberculosis failed to produce the precipitin antibody to cord factor in man and animals, indicating that this humoral antibody against cord factor is associated with neither the immune state elicited by live BCG vaccine nor the infection with virulent tubercle bacilli.
It has been reported recently by Bekierkunst et al. (1) that the intravenous injection of cord factor-in-oil emulsified in Tween-saline induced a granuloma formation in the lungs of mice, as did live BCG vaccine, and also a certain level of resistance to the infection with tubercle bacilli. This effect of cord factor was attributed to an elevated phagocytic activity of macrophages in the granulomatous tissue and therefore considered to be of nonspecific nature (3) . Later communication from these authors indicated that cord factor, as well as BCG cells, injected into footpads of mice induced in the draining lymph nodes the hyperplasia of lymphoid tissue (2) and an enhanced immune response to an unrelated antigen as sheep red blood cells (4) . However, the mechanism of the protection of tuberculous infection by the vaccination with cord factor-MBSA complex is entirely different from this case. First, the aqueous emulsion of cord factor was completely ineffective to protect mice against both the toxic action of cord factor (12) and the infection with tubercle bacilli when it was injected subcutaneously into mice with Freund incomplete adjuvant. Secondly, a precipitin antibody to cord factor was produced in animals by the repeated subcutaneous vaccination with cord factor-MBSA complex which could neutralize the toxicity of cord factor and display an infection-protecting 
